HiFiBiO Therapeutics Secures $37.5 Million Series B Financing to Accelerate Pipeline of Novel Antibody Drugs to Treat Cancer and Autoimmune Disorders Life Science
China’s Zhejiang Huahai Pharma Receives US Regulatory Approval for Its Cardiovascular Generic Drug Life Science